Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,836.58
(
-0.20%
)
News Focus
News Focus
Post# of 9090
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

IanFromSI

Send PM Follow Ignore
Followers 13
Posts 874
Boards Moderated 0
Alias Born 03/17/2011

IanFromSI

Re: vinmantoo post# 3101

Thursday, 12/22/2022 4:19:33 PM

Thursday, December 22, 2022 4:19:33 PM

Post# of 9090
Frequently, with emerging bio techs, when the primary drug in the pipeline is approved, the institutions start pricing those stocks based on actual expected earnings rather than the hopes and dreams that have driven the stock price during the past years.

I suspect that is the transition Revance is now going through

Seasons greetings to all,
Ian
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote